Preventive effect of pentoxifylline on renal scarring in rat model of pyelonephritis

Urology

Volumn 61, Issue 5, 2003, Pages 1037-1041

  Yagmurlu, Aydin ^a   Boleken, M Emin ^b   Ertoy, Dilek ^b   Ozsan, Murat ^b   Gokcora, I Haluk ^b   Dindar, Huseyin ^b  

^a NONE   (Turkey)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

CIPROFLOXACIN; METHYLXANTHINE DERIVATIVE; PENTOXIFYLLINE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIMICROBIAL THERAPY; ARTICLE; BACTERIAL STRAIN; BACTERIUM COLONY; BACTERIUM PILUS; CHRONIC PYELONEPHRITIS; COLONY FORMING UNIT; CONTROLLED STUDY; DRUG EFFICACY; ESCHERICHIA COLI K 12; FEMALE; HISTOPATHOLOGY; INFECTION PREVENTION; INJECTION; INOCULATION; KIDNEY PARENCHYMA; KIDNEY SCAR; NONHUMAN; PRIORITY JOURNAL; RAT; SPECIES COMPARISON;

EID: 0037963312     PISSN: 00904295     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0090-4295(02)02428-7     Document Type: Article

References (31)

1. Hodson C.J., Maling T.M., McManamon P.J., et al. The pathogenesis of reflux nephropathy (chronic atrophic pyelonephritis). Br J Radiol. 13:(suppl):1975;1-26.
2. Scott J.E., Stansfeld J.M. Ureteric reflux and kidney scarring in children. Arch Dis Child. 43:1968;468-470.
3. Slotki I.N., Asscher A.W. Prevention of scarring in experimental pyelonephritis in the rat by early antibiotic therapy. Nephron. 30:1982;262-268.
4. Glauser M.P., Lyons J.M., Braude A.I. Prevention of chronic experimental pyelonephritis by suppression of acute suppuration. J Clin Invest. 61:1978;403-407.
5. McLorie G.A., McKenna P.H., Jumper B.M., et al. High grade vesicoureteral reflux analysis of observational therapy . J Urol. 144:(2 Pt 2):1990;537-545.
6. Matsumoto T., Mizunoe Y., Sakamoto N., et al. Suitability of colchicine and superoxide dismutase for the suppression of renal scarring following an infection with bacteria showing mannose-sensitive pili. Nephron. 56:1990;130-135.
7. Matsumoto T., Mizunoe Y., Ogata N., et al. Role of superoxide in renal scarring following infection by mannose-sensitive piliated bacteria. Urol Res. 19:1991;229-233.
8. Matsumoto T., Mitzunoe Y., Ogata N., et al. Antioxidant effect on renal scarring following infection of mannose-sensitive-piliated bacteria. Nephron. 60:1992;210-215.
9. Roberts J.A., Roth J.K. Jr, Domingue G., et al. Immunology of pyelonephritis in the primate model. V. Effect of superoxide dismutase. J Urol. 128:1982;1394-1400.
10. Haraoka M., Matsumoto T., Mizunoe Y., et al. Effect of prednisolone on renal scarring in rats following infection with Serratia marcescens. Ren Fail. 15:1993;567-571.
11. Meylan P.R., Markert M., Bille J., et al. Relationship between neutrophil-mediated oxidative injury during acute experimental pyelonephritis and chronic renal scarring. Infect Immun. 57:1989;2196-2202.
12. Matsumoto T., Mizunoe Y., Sakamoto N., et al. Increased renal scarring by bacteria with mannose-sensitive pili. Urol Res. 18:1990;299-303.
13. Ward A., Clissold S.P. Pentoxifylline a review of its pharmacodynamic and pharmacokinetic properties and its therapeutic efficacy . Drugs. 34:1987;50-97.
14. Skjeldal S., Hvaal K., Nordsletten L., et al. Pentoxifylline reduces skeletal muscle necrosis after acute hindlimb ischemia in rats. Eur Surg Res. 26:1994;94-100.
15. Kavukcu S., Soylu A., Turkmen M., et al. The role of vitamin A in preventing renal scarring secondary to pyelonephritis. BJU Int. 83:1999;1055-1059.
16. Bennett R.T., Mazzaccaro R.J., Chopra N., et al. Suppression of renal inflammation with vitamins A and E in ascending pyelonephritis in rats. J Urol. 161:1999;1681-1684.
17. Bille J., Glauser M.P. Protection against chronic pyelonephritis in rats by suppression of acute suppuration effect of colchicine and neutropenia . J Infect Dis. 146:1982;220-226.
18. Khalil A., Brauner A., Bakhiet M., et al. Cytokine gene expression during experimental Escherichia coli pyelonephritis in mice. J Urol. 158:1997;1576-1580.
19. Haraoka M., Matsumoto T., Takahashi K., et al. Suppression of renal scarring by prednisolone combined with ciprofloxacin in ascending pyelonephritis in rats. J Urol. 151:1994;1078-1080.
20. Haraoka M., Matsumoto T., Mizunoe Y., et al. Effect of ebselen on renal scarring in rats following renal infection. Chemotherapy. 41:1995;208-213.
21. Matsumoto T., Haraoka M., Mizunoe Y., et al. Preventive effect of ulinastatin on renal scarring in rat model of pyelonephritis induced by direct or ascending infection with Serratia marcescens or Escherichia coli. Nephron. 69:1995;65-70.
22. Savas C., Aras T., Cakmak M., et al. Pentoxifylline inhibits overflow and reduces intestinal reperfusion injury. J Pediatr Surg. 32:1997;905-910.
23. Strutz F., Heeg M., Kochsiek T., et al. Effects of pentoxifylline, pentifylline and gamma-interferon on proliferation, differentiation, and matrix synthesis of human renal fibroblasts. Nephrol Dial Transplant. 15:2000;1535-1546.
24. Duncan M.R., Hasan A., Berman B. Pentoxifylline, pentifylline, and interferons decrease type I and III procollagen mRNA levels in dermal fibroblasts evidence for mediation by nuclear factor 1 down-regulation . J Invest Dermatol. 104:1995;282-286.
25. Berman B., Duncan M.R. Pentoxifylline inhibits normal human dermal fibroblast in vitro proliferation, collagen, glycosaminoglycan, and fibronectin production, and increases collagenase activity. J Invest Dermatol. 92:1989;605-610.
26. Berman B., Duncan M.R. Pentoxifylline inhibits the proliferation of human fibroblasts derived from keloid, scleroderma and morphoea skin and their production of collagen, glycosaminoglycans and fibronectin. Br J Dermatol. 123:1990;339-346.
27. Chang C.C., Chang T.C., Kao S.C., et al. Pentoxifylline inhibits the proliferation and glycosaminoglycan synthesis of cultured fibroblasts derived from patients with Graves' ophthalmopathy and pretibial myxoedema. Acta Endocrinol (Copenh). 129:1993;322-327.
28. Windmeier C., Gressner A.M. Effect of pentoxifylline on the fibrogenic functions of cultured rat liver fat-storing cells and myofibroblasts. Biochem Pharmacol. 51:1996;577-584.
29. Jutley R.S., Youngson G.G., Eremin O., et al. Serum cytokine profile in reflux nephropathy. Pediatr Surg Int. 16:2000;64-68.
30. Ninan G.K., Jutley R.S., Eremin O. Urinary cytokines as markers of reflux nephropathy. J Urol. 162:1999;1739-1742.
31. Windmeier C., Gressner A.M. Pharmacological aspects of pentoxifylline with emphasis on its inhibitory actions on hepatic fibrogenesis. Gen Pharmacol. 29:1997;181-196.